Cite
HARVARD Citation
Chen, B. et al. (2022). Acalabrutinib CYP3A‐mediated drug–drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy. British journal of clinical pharmacology. 88 (8), pp. 3716-3729. [Online].